The Mishcon Innovations Series

• Peter Crane: Co-founder and CEO of Entelo Bio

  Peter Crane is the co-founder and CEO of Entelo Bio, a gene sequencing company combining cutting edge chemistry with machine learning to unlock transformative therapies for patients with chronic diseases. With a career spanning lab automation, biomanufacturing and cancer proteomics (and as an invester in hard science Start-ups), it was his frustration with existing genomic methods that drove Peter and his 3 academic co-founders to spin Entelo Bio out of Oxford University in 2023. Hungry to look at biology in a new way, their isoform sequencing platform aims to reduce the error rate and cost of long read single cell sequencing.

  --------  

  21:20

  --------

  21:20
• Ethan Fraenkel: Co-founder and CEO of Prograd

  Ethan Fraenkel is the co-founder and CEO of Prograd, a fast-growing UK fintech platform empowering Gen Z to earn side income and improve their financial future. Born in Antwerp, Belgium, Ethan moved to Tel Aviv at the age of 18, where he was first immersed in the world of tech and startups. At 20, he relocated to London, where he studied Law and Politics at Queen Mary University of London, before going on to complete a Master’s in Computer Science at University College London (UCL). This unique blend of legal, political, and technical expertise laid the foundation for his entrepreneurial journey. He spent three years at Cutover, a London and New York-based tech startup, where he gained hands-on experience being a software and cloud engineer in a high-growth environment. Ethan later co-founded Prograd to solve a problem he witnessed firsthand: helping young people earn more, gain financial independence, and build a stronger financial foundation. Today, Prograd serves over 1 millions users, driven by Ethan’s mission to close the opportunity gap for the next generation.

  --------  

  21:02

  --------

  21:02
• Bianca Rangecroft: Founder and CEO of Whering

  Bianca is the founder and CEO of Whering, the fashion app that allows you to digitise your wardrobe, see and style what you own. She is on a mission to upend the ‘buy, use, dispose’ model and use AI to help us make the most of the clothes we already own. Since Jan 2022, Bianca has grown Whering’s user base to over 8m users, raised >£4m and has been featured in Vogue, Harper’s, Forbes etc. She is fluent in five European languages and holds a first class Bachelor’s degree in History and Politics from SOAS & LSE as well as a Master’s degree in Management (Merit) from Imperial College Business School. Bianca spent the first 4.5 years of her career in Banking, first at Barclays Investment Management and then in Goldman Sachs’ consumer division in London. She is a board member of Imperial College’s Alumni Advisory board, the London Chapter President for Unite2030 and an UNLEASH 2019 & 2020 Global Talent. She is also a frequent TV, podcast and radio guest, recently appearing on Dragon’s Den, BBC radio etc. She’s been awarded the Women in the City award and Drapers30u30 and shortlisted for Tech innovator of the year (Drapers) and the Great British Entrepreneur awards.

  --------  

  31:56

  --------

  31:56
• Max Munford: Founder and CEO at OSSTEC

  Max Munford is the Founder and CEO at OSSTEC, the MedTech company on a mission to transform orthopaedic surgery through cutting-edge 3D printing technology. His role focuses on company vision, strategy and growing OSSTEC's team. Max has a passion for learning, growing the bounds of technology and for delivering impact across MedTech. He completed his PhD at Imperial College London, developing biomimetic 3D printing for use in orthopaedics. His work building OSSTEC earned him a place on the prestigious Forbes 30 Under 30 list in 2025 and his research has won awards across the field including places on some of Europe's best venture accelerator programs and executive education programs at Harvard Business School.

  --------  

  29:19

  --------

  29:19
• Lindsay Edwards: CTO and Head of Platform at Relation Therapeutics

  Lydia Kellett is joined by Lindsay Edwards, CTO and Head of Platform at Relation Therapeutics. Previously, Lindsay was VP and Head of AI for Respiratory and Immunology at AstraZeneca. Originally a specialist in systems biology, he joined GlaxoSmithKline in 2014 from the Physiology faculty at King’s College London. He started GSK’s first Data Science group, was Head of Respiratory Data Sciences, Global Head of Respiratory Digital, Data and Analytics, and then VP and Head of AI/ML for the UK and Europe before becoming VP of AI/ML Engineering. He holds a DPhil in Physiology from Oxford, is a scientific advisor to the Eric and Wendy Schmidt Centre at MIT, and has published more than 40 articles in peer-reviewed journals.

  --------  

  32:41

  --------

  32:41

More Business podcasts

Trending Business podcasts

About The Mishcon Innovations Series

The Mishcon Innovations Series: Podcasts in Family